Skip to main content
. 2017 Dec 13;2017(12):CD000467. doi: 10.1002/14651858.CD000467.pub2

Comparison 2. Subgroup analysis by RP type.

Outcome or subgroup title No. of studies No. of participants Statistical method Effect size
1 Frequency of attacks (average/week) 15 624 Mean Difference (Fixed, 95% CI) ‐3.15 [‐3.67, ‐2.63]
1.1 CCBs vs placebo for primary RP 12 420 Mean Difference (Fixed, 95% CI) ‐3.02 [‐3.65, ‐2.38]
1.2 CCBs vs placebo for secondary RP 9 204 Mean Difference (Fixed, 95% CI) ‐3.42 [‐4.33, ‐2.51]
2 Severity of attacks (average, on a 10‐cm VAS) 10 506 Mean Difference (Fixed, 95% CI) ‐0.67 [‐0.77, ‐0.57]
2.1 Primary RP: CCBs vs placebo 8 368 Mean Difference (Fixed, 95% CI) ‐0.95 [‐1.11, ‐0.79]
2.2 Secondary RP: CCBs vs placebo 6 138 Mean Difference (Fixed, 95% CI) ‐0.48 [‐0.61, ‐0.35]